Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Establishing a phase I unit: organisation.

D de Lauture1, A Kahan, J L Pinquier

  • 1Institut de Recherche Thérapeutique, Hôpital Cochin, Paris, France.

Fundamental & Clinical Pharmacology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.

Seminars in arthritis and rheumatism·2018
Same author

Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.

Clinical and experimental rheumatology·2014
Same author

Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014
Same author

[The minute structure of the macula region in connection with function tests in tapetoretinal degeneration].

A.M.A. archives of ophthalmology·2014
Same author

[Problem of early diagnosis in rheumatic diseases; changes in the leukogram and V.S.H. after intradermal injection of streptococcic antigen].

Probleme de reumatologie·2014
Same author

[Prevention of rheumatic diseases in school-age children].

Probleme de reumatologie·2014
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms.

Fundamental & clinical pharmacology·2026
Same journal

TAAR1-Associated Trace Amines for Cutaneous Nociceptive Blockade in Rats.

Fundamental & clinical pharmacology·2026
Same journal

Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia-Reperfusion Injury.

Fundamental & clinical pharmacology·2026
Same journal

Probucol Exerts Anticancer Effects on SW480 Human Colorectal Cancer Cells via Modulation of Apoptosis- and Angiogenesis-Related Proteins.

Fundamental & clinical pharmacology·2026
Same journal

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity.

Fundamental & clinical pharmacology·2026
Same journal

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology·2026
See all related articles

Establishing a phase I clinical pharmacology unit requires prioritizing safety, quality, and scientific rigor. This involves highly qualified staff, intensive care resources, and collaborative efforts led by a clinical pharmacologist.

Area of Science:

  • Clinical Pharmacology
  • Drug Development

Background:

  • Phase I units are critical for early-stage drug safety and efficacy studies.
  • Successful organization requires adherence to stringent safety, quality, and scientific standards.

Purpose of the Study:

  • To outline the essential organizational requirements for a phase I clinical pharmacology unit.
  • To emphasize the necessary resources and personnel for effective study implementation.

Main Methods:

  • Review of organizational best practices for phase I units.
  • Identification of key personnel and equipment requirements.
  • Emphasis on collaborative research models.

Main Results:

  • Phase I units necessitate a highly qualified, multidisciplinary staff.

Related Experiment Videos

  • Availability of intensive care equipment is crucial for patient safety.
  • Investigator expertise in clinical pharmacology and project leadership is essential.

    • Conclusions:

    • Effective phase I unit organization hinges on robust safety protocols and quality management.
    • Collaboration between clinical pharmacologists and specialized consultants ensures successful study execution.
    • Adequate resources, including skilled personnel and advanced equipment, are fundamental.